Canon Marketing Japan MIRAI Fund
VC Fund
Canon Marketing Japan MIRAI Fund is a CVC fund of Canon Marketing Japan that supports and invests in startups. It is operated by Global Brain Corporation.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 37%
Last updated:
For AI agents: llms.txt
Industries Canon Marketing Japan MIRAI Fund invests in
Stages Canon Marketing Japan MIRAI Fund invests in
Countries Canon Marketing Japan MIRAI Fund invests in
Round sizes
Round size
- Seed
- $652k–$652k
- Series A
- $6.7M–$63M
- Series B
- $4M–$8.4M
Investment Focus
Industry
- Artificial Intelligence 3 (16%)
- Content 2 (11%)
- Health Care 2 (11%)
- Food Processing 2 (11%)
- Food and Beverage 2 (11%)
Stage
- Series B 5 (26%)
- Seed 3 (16%)
- Series A 3 (16%)
- Venture - Series Unknown 3 (16%)
- Funding Round 2 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Metagen Therapeutics
|
Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $7.7M / Series B / Feb 25, 2026 | |
Anique
|
Anique is a service that utilizes blockchain technology to make artworks. | $8.4M / Series B / Feb 24, 2026 | |
AI Model
|
AI model specializes in the development and transformation of real-like virtual models for modeling on E-commerce platforms. | Series B / Jan 23, 2026 | |
Olive
|
Olive is developing a business that uncovers causal relationships between emotions and the background of human behavior and decision-making through the analysis of biometric data. | Seed / Jan 19, 2026 | |
Turing
|
Turing develops and manufactures fully autonomous vehicles. | $62.9M / Series A / Nov 17, 2025 | |
SAKANA Dream
|
SAKANA Dream develops unique farmed fish species by leveraging an innovative breeding technology "Surrogate Broodstock Technology". The company selects outstanding fish from over 4,000 species living in Japan and produces remarkable hybrid fish which have both great taste and high productivity. | $6.7M / Series A / Sep 02, 2025 | |
Cierpa & Company
|
Cierpa & Company develops environmental, social, and governance management software. They offer services for the cloud, share information between departments, optimise workflows, and analyse and improve scores. | $6.8M / Series B / Aug 28, 2025 | |
Idein
|
Idein is a company specializing in AI technology, with the objective of allowing all real-world events to be managed by software through the use of pattern recognition and signal processing technologies. The firm focuses on creating machine learning models, application applications, and enhancing inference speed. Inference of trained models can beexecuted on affordable, commercially available computers by utilizing acceleration technology. Idein offers Actcast, which was developed to address the necessity for a marketplace and simplified access to real-world information gathering applications from various vendors. This initiative aims to provide a cohesive UI/UX and to lower costs by consolidating devices and infrastructure, thereby facilitating the implementation of advanced technology. | Venture - Series Unknown / Jul 22, 2025 | |
|
Olive
|
Olive is developing a business that uncovers causal relationships between emotions and the background of human behavior and decision-making through the analysis of biometric data. | Seed / Jun 10, 2025 | |
10x
|
10x provides One-stop service from meal planning to grocery shopping. | $14.8M / Venture - Series Unknown / Apr 28, 2025 | |
| See all 19 investments → | |||
Co-Investors
Global Brain Corporation
14 deals together
Mercuria Investment
4 deals together
Mitsubishi UFJ Capital
4 deals together
ANA Future Frontier Fund
2 deals together
Ask Capital
2 deals together
Future Food Fund
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Canon Marketing Japan MIRAI Fund invest in?
Canon Marketing Japan MIRAI Fund invests primarily in Artificial Intelligence, Content and Health Care startups, most often at Series B and Seed stage. Most of the 19 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Canon Marketing Japan MIRAI Fund's check size?
Canon Marketing Japan MIRAI Fund typically joins rounds of $652k–$652k at Seed, $6.7M–$63M at Series A and $4M–$8.4M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Canon Marketing Japan MIRAI Fund participates in.
When did Canon Marketing Japan MIRAI Fund last invest?
The most recent investment recorded for Canon Marketing Japan MIRAI Fund closed in Feb 2026. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
